|
ICP27 protein, Marek's disease virus
|
C089456 |
|
|
9-(5,6-dideoxy-6-iodo-ribo-hex-5-ynofuranosyl)adenine
|
C114812 |
|
|
Bradykinin B2 Receptor Antagonists
|
D065094 |
[Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ B2 RECEPTORS.
] |
|
2-chloro-9-(4-thioarabinofuranosyl)adenine
|
C114813 |
|
|
Calcineurin Inhibitors
|
D065095 |
[Compounds that inhibit or block the PHOSPHATASE activity of CALCINEURIN.
] |
|
2,5-bis((N-cyclopentylamidino)phenyl)furan
|
C114814 |
|
|
Calcium Chelating Agents
|
D065096 |
[Substances that bind to and sequester CALCIUM ions.
] |
|
8-deoxyhemigossylic acid
|
C114815 |
|
|
Carbamoyl Phosphate Synthetase I Activators
|
D065097 |
[Substances and drugs that stimulate the synthesis or increase the activity of CARBAMOYL PHOSPHATE SYNTHETASE I. Drugs in this class of compounds have been used to treat the genetic disorder, CARBAMOYL-PHOSPHATE SYNTHASE I DEFICIENCY DISEASE.
] |
|
naamidine A
|
C114816 |
|
|
Catechol O-Methyltransferase Inhibitors
|
D065098 |
[Compounds and drugs that inhibit or block the activity of CATECHOL O-METHYLTRANSFERASE enzymes. Drugs in this class are used in management of central nervous system disorders such as PARKINSON DISEASE.
] |
|
PhaA protein, Sinorhizobium meliloti
|
C114817 |
|
|
Travel Nursing
|
D065099 |
[A type of nursing practice involving licensed professional nurses who travel to work in temporary nursing positions.
] |
|
WbpL protein, Pseudomonas
|
C114818 |
|
|
Zur protein, E coli
|
C114819 |
|
|
benzyl 3,3,5-trimethylcyclohexyl ether
|
C089470 |
|
|
9-(6-chloro-5,6-dideoxy-ribo-hex-5-ynofuranosyl)adenine
|
C114810 |
|
|
9-(6-bromo-5,6-dideoxy-ribo-hex-5-ynofuranosyl)adenine
|
C114811 |
|
|
5,9,13-trimethyltetradecanoic acid
|
C089468 |
|
|
3-(4-(3-(1H-imidazol-1-yl)propoxy)phenyl)-5-trifluoromethyl-1,2,4-oxadiazole
|
C089469 |
|
